CoChat

Metabolic consequences of modern immunosuppressive agents in solid organ transplantation

Open access
Bamgbola, Oluwatoyin · 2016 · Therapeutic Advances in Endocrinology and Metabolism

The DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.

Abstract

Among other factors, sophistication of immunosuppressive (IS) regimen accounts for the remarkable success attained in the short- and medium-term solid organ transplant (SOT) survival. The use of steroids, mycophenolate mofetil and calcineurin inhibitors (CNI) have led to annual renal graft survival rates exceeding 90% in the last six decades. On the other hand, attrition rates of the allograft beyond the first year have remained unchanged. In addition, there is a persistent high cardiovascular (CV) mortality rate among transplant recipients with functioning grafts. These shortcomings are in part due to the metabolic effects of steroids, CNI and sirolimus (SRL), all of which are implicated in hypertension, new onset diabetes after transplant (NODAT), and dyslipidemia. In a bid to reduce the required amount of harmful maintenance agents, T-cell-depleting antibodies are increasingly used for induction therapy. The downsides to their use are greater incidence of opportunistic viral infections and malignancy. On the other hand, inadequate immunosuppression causes recurrent rejection episodes and therefore early-onset chronic allograft dysfunction. In addition to the adverse metabolic effects of the steroid rescue needed in these settings, the generated proinflammatory milieu may promote accelerated atherosclerotic disorders, thus setting up a vicious cycle. The recent availability of newer agent, belatacept holds a promise in reducing the incidence of metabolic disorders and hopefully its long-term CV consequences. Although therapeutic drug monitoring as applied to CNI may be helpful, pharmacodynamic tools are needed to promote a customized selection of IS agents that offer the most benefit to an individual without jeopardizing the allograft survival.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/2042018816641580

Cites

141 of 141 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 141 references

Research works printed but not linked: 12

  1. 10.1186/2047144021 · doi:10.1186/2047144021
  2. Einollahi B., 2014, J Nephropathol, 3, 139
  3. Juan Khong M., 2014, Neth J Med, 72, 127
  4. Masson P., 2014, Cochrane Database Syst Rev, 11, CD010699
  5. Pascual J., 2009, Cochrane Database Syst Rev, 4, CD007669
  6. Pourmand G., 2015, Acta Med Iran, 53, 297
  7. Razeghi E., 2011, Exp Clin Transplant, 9, 230
  8. Taber D., 2013, Ethn Dis, 23, 238
  9. Turgay M., 2012, Bratisl Lek Listy, 113, 10
  10. Webster A., 2010, Cochrane Database Syst Rev, 1, CD003897
  11. Webster A., 2005, Cochrane Database Syst Rev, 4, CD003961
  12. Wjidan K., 2015, J Clin Diagn Res, 9, OF06

Cited by

See all 92

Metadata

Authors
Bamgbola, O.
Affiliations
SUNY Downstate Health Sciences University (US)
Corresponding author
Bamgbola, Oluwatoyin
Venue
Therapeutic Advances in Endocrinology and Metabolism
Published
2016-03-30
Volume
7
Issue
3
Pages
110-127
ISSN
  • 2042-0188 (ISSN-L)
  • 2042-0196
OpenAlex
W2320017047
Cited by
85
References
141
Citations by year
2026: 7 · 2025: 8 · 2024: 7 · 2023: 2 · 2022: 12 · 2021: 12 · 2020: 6 · 2019: 9 · 2018: 8 · 2017: 11 · 2016: 3
FWCI
2.45
Type
journal article
Language
en
Open access
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Therapeutic Advances in Endocrinology and Metabolism (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
  • Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
  • Health Sciences › Medicine › Transplantation › Organ and Tissue Transplantation Research
Keywords
immunosuppressants, solid organ transplantation, metabolic complications, calcineurin inhibitors, rapamycin, corticosteroids, mycophenolate mofetil, post-transplant diabetes mellitus, hypertension, dyslipidemia, cardiovascular mortality, belatacept, chronic allograft dysfunction, atherosclerosis, therapeutic drug monitoring, personalized immunosuppression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metabolic consequences of modern immunosuppressive agents in solid organ transplantation. https://app.cochat.ai/papers/10.1177/2042018816641580
The paper
Bamgbola, O. (2016). Metabolic consequences of modern immunosuppressive agents in solid organ transplantation. Therapeutic Advances in Endocrinology and Metabolism. https://doi.org/10.1177/2042018816641580

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.